Literature DB >> 21445417

A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α.

K Siva Kumar1, P Mahesh Kumar, K Anil Kumar, M Sreenivasulu, Ahamed A Jafar, D Rambabu, G Rama Krishna, C Malla Reddy, Ravikumar Kapavarapu, K Shivakumar, K Krishna Priya, Kishore V L Parsa, Manojit Pal.   

Abstract

Concurrent construction of five and six membered fused N-heretocyclic ring was achieved via a conceptually new three-component reaction affording 6,6a-dihydroisoindolo[2,1-a]quinazoline-5,11-diones as novel inhibitors of TNF-αin vitro. This represents one of the few examples of direct TNF-α inhibition by small molecules. © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445417     DOI: 10.1039/c1cc10715a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Transition metal-free one-pot synthesis of nitrogen-containing heterocycles.

Authors:  Simpal Kumari; Dharma Kishore; Sarvesh Paliwal; Rajani Chauhan; Jaya Dwivedi; Aakanksha Mishra
Journal:  Mol Divers       Date:  2015-06-09       Impact factor: 2.943

2.  Synthesis of novel fused quinazolinone derivatives.

Authors:  Mohammad Mahdavi; Vahid Lotfi; Mina Saeedi; Ebrahim Kianmehr; Abbas Shafiee
Journal:  Mol Divers       Date:  2016-05-21       Impact factor: 2.943

3.  Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities.

Authors:  Gaoyin Wu; Xuejiao J Gao; Joonkyung Jang; Xingfa Gao
Journal:  J Mol Model       Date:  2016-06-18       Impact factor: 1.810

4.  In silico studies for the interaction of tumor necrosis factor-alpha (TNF-α) with different saponins from Vietnamese ginseng (Panax vietnamesis).

Authors:  Oanh T P Kim; Manh D Le; Hoang X Trinh; Hai V Nong
Journal:  Biophys Physicobiol       Date:  2016-07-14

Review 5.  Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions.

Authors:  Francisco Sánchez-Sancho; Marcos Escolano; Daniel Gaviña; Aurelio G Csáky; María Sánchez-Roselló; Santiago Díaz-Oltra; Carlos Del Pozo
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.